The Pre-Filled Syringes Market: 2015-2030
Description
- Pre-Filled
Syringes
Market
A
pre-filled syringe is a medical syringe that comes pre-filled with a
specific dosage of medication. Representing one of the fastest
growing segments of the injectable drug delivery ecosystem,
pre-filled syringes offer significant benefits over the traditional
‘vial and syringe’ format, by increasing dosing accuracy, safety
and convenience.
In
addition, pre-filled syringes also offer a variety of economic
benefits to pharmaceutical companies including a reduction in drug
overfill and waste, which increases the saleable yield of the API
(Active Pharmaceutical Ingredient).
SNS
Research estimates that the market for pre-filled syringes will
account for over $3.2 Billion in revenue by the end of 2015. Despite
challenges relating to drug stability, manufacturing and competition
from other drug delivery technologies, the market is poised for
significant growth in the coming years. Expected to grow at a CAGR
of 13% between 2015 and 2020, the market will account for nearly $6
Billion in revenue by the end of 2020.
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/the-pre-filled-syringes-market-2015-2030-report.html
The
“Pre-Filled Syringes Market: 2015 – 2030 – Opportunities,
Challenges, Strategies & Forecasts” report presents an in-depth
assessment of the pre-filled syringes ecosystem including technology,
market drivers, challenges, investment potential, leading therapies,
use cases, opportunities, future roadmap, value chain, ecosystem
player profiles and strategies. The report also presents market size
forecasts for pre-filled syringe unit sales from 2015 through to
2030. The forecasts are further segmented for 4 horizontal
submarkets, 10 drug classes, 5 regions and 13 leading countries.
The
report comes with an associated Excel datasheet suite covering
quantitative data from all numeric forecasts presented in the report.
Key
Findings:
The
report has the following key findings:
SNS
Research estimates that the market for pre-filled syringes will
account for over $3.2 Billion in revenue by the end of 2015. Expected
to grow at a CAGR of 13% between 2015 and 2020, the market will
account for nearly $6 Billion in revenue by the end of 2020
Many
pre-filled syringe manufacturers now also offer integrated automatic
needle shielding or retractable needle options
While
glass continues to remain the gold standard for pre-filled syringes,
the proportion of plastic based pre-filled syringes is expected to
increase by 5% between 2015 and 2020, due to concerns of glass
breakage and plunger failure
A
number of pre-filled syringe manufacturers have developed dual and
multi chambered syringes, to cater for drugs that must be
reconstituted at the point of delivery
Pre-filled
pen systems and auto-injectors will grow at a CAGR of more than 20%
over the next five years
Topics
Covered:
The
report covers the following topics:
Pre-filled
syringes ecosystem
Market
drivers and barriers
Technology,
safety mechanisms and key trends
Pen
systems and auto-injectors
Industry
roadmap and value chain
Analysis
of leading drug classes and pre-filled syringe therapies
Profiles
and strategies of 55 leading ecosystem players, including
manufacturers and pharmaceutical giants
Strategic
recommendations for ecosystem players
Market
analysis and forecasts from 2015 till 2030
Historical
Revenue & Forecast Segmentation:
Market
forecasts are provided for each of the following submarkets and their
subcategories:
Material
Glass
Plastic
Injector
Type
Conventional
Pen
Systems & Auto-Injectors
Drug
Class
MAbs
(Monoclonal Antibodies)
Insulins
Erythropoietins
Interferons
G-CSF
Agents
Anticoagulants
& Recombinant Coagulation Factors
Biosimilars
& Follow-on Protein Products
Vaccines
Growth
Hormones
Others
Regional
Markets
Asia
Pacific
Europe
Middle
East & Africa
North
America
Latin
& Central America
Country
Markets
Brazil
Canada
China
France
Germany
India
Italy
Japan
Korea
Russia
Spain
UK
USA
Key
Questions Answered:
The
report provides answers to the following key questions:
How
big is the pre-filled syringes opportunity?
What
factors are influencing its growth?
How
is the ecosystem evolving by segment and region?
What
will the market size be in 2020 and at what rate will it grow?
What
trends, challenges and barriers are influencing its growth?
Who
are the key market players and what are their strategies?
Which
countries and submarkets will see the highest percentage of growth?
How
will patent expiries of biologics impact the pre-filled syringes
market?
What
are the future prospects of multi chamber pre-filled syringes?
How
does regulation impact pre-filled syringes?
What
strategies should pre-filled syringe manufacturers adopt to remain
competitive?
List
of Companies Mentioned:
The
following companies and organizations have been reviewed, discussed
or mentioned in the report:
Abbott
Laboratories
Amgen
AMRI
(Albany Molecular Research, Inc.)
Aptar
Stelmi
AptarGroup
Artemes
Technologies
AstraZeneca
Battelle
Baxter
International (Baxter BioPharma Solutions)
BD
(Becton, Dickinson and Company)
Bespak
Biocon
For
More Information Kindly Contact:
ResearchMoz
Global Pvt. Ltd.
90
State Street,
Albany,
NY 12207,
United
States
866-997-4948
(Us-Canada Toll Free),
+1-518-621-2074,
Comments
Post a Comment